Erzählungen und Novellen des 19. Jahrhunderts: brieven van Reijnier Flaes aan Axel Huber
Terborgh, F. C. ; Huber, Axel ; Rosendahl Huber, Axel ¬[Hrsg.]¬
Stuttgart. Reclam. 1988. 422 S.. Universal-Bibliothek ; 8413.
ISBN 3-15-008413-X

FC Thun: Meteor am Schweizer Fussballhimmel
Krebser, Markus ¬[Hrsg.]¬
Thun. Krebser Thun. c 2003. 129 S..
ISBN 3-85777-146-1 : Pp. : sfr 40.00

FC Thun: Griff nach Europas Fussballsternen ; [Medienkombination]
Gygax, René E. ¬[Hrsg.]¬
Thun. Krebser. 2005. 161 S..
ISBN 3-85777-148-8

Aus 650 Jahren: Ausgewählte Dokumente des Stadtarchivs Augsburg zur Geschichte der Reichsstadt Augsburg 1156-1806
Wieland, Ute ¬ ¬[Regie¬]¬ ; Fleischmann, Peter ; Herde, Simone ; Tschirner, Nora ¬ ¬[Darst¬.]¬ ; Ulmen, Christian ¬ ¬[Darst¬.]¬ ; Lukas, Florian ¬ ¬[Darst¬.]¬
Augsburg, Bay. Wißner-Verlag. 2006. 128 S.. Beiträge zur Geschichte der Stadt Augsburg ; 3.
3-89639-543-2

FC Venus
Tschirner, Nora
Package Design Euro Video. 2006. 95 min.
ISBN 400-9-7502-3023-7

FC Venus - Angriff ist die beste Verteidigung
Wieland, Ute
DVD. Deutschland. 2006. 1 DVD.

FC Venus (DVD)
DVD-Video.

F. C. Vogel's Panorama des Rheins oder Ansichten des rechten und linken Rheinufers von Mainz bis Coblenz
Vogel, Friedrich Christian Wilhelm ; Dielmann, Jakob Fürchtegott ; Fay, A. ; Becker, Jakob
Frankfurt am Main. Vogel. 1830. [3] Bl..

FCV-shisutemu-asshuku-suiso-yoki-to-sono-anzen: 2006 JSAE annual congress, Yokohama, May 26
TÅokyÅo. Kai. 2006. 28 S.. Gakujutsu kÅoenkai maezurishÅu ; 70-06.

F. C. Weidmann's sämmtliche Werke
Weidmann
Brünn . 1821-23. 1-3 i 5 bd..

F.C. Weiskopf: 1900-1955
Greuner, Ruth
Berlin . Deutscher Kulturbund. 1960. 223 S..

F. C. Weiskopf 1900 - 1955
Weiskopf, Franz C. ; Greuner, Ruth ¬[Sonst.]¬
Als Ms. gedr.. Berlin. Dt. Kulturbund. 1960. 223 S..

F. C. Weiskopf. Gesammelte Werke
Weiskopf, Franz Karl ; Weiskopf, Grete _ ¬[Bearb.]¬ ; Hermlin, Stephan _ ¬[Bearb.]¬
Berlin. Dietz.

F.C. Weiskopf - Schriftsteller und Kritiker: Zur Entwicklung seiner literarischen Anschauungen
Glaeser, Ernst
Berlin [u.a.]. Aufbau-Verl.. 1973. 398 S. Bibliogr. S. 357-389.

FC windmill regulations
Bugge
[Hurup Thy] . Nordvestjysk Folkecenter for Vedvarende Energi. 1988 . 8 s..

FDA: inside & out
Parisian, Suzanne
1. ed. Front Royal, VA. Fast Horse Press. 2001. xix, 647 p..
ISBN 0-9707109-1-7

FDA administrative enforcement manual
Parker, Florence R.
Boca Raton, FL. CRC Press. 2005. p. cm.
ISBN 0-8493-3067-X alk. paper

FDA almanac
Rockville, MD. Office of Public Affairs, Food and Drug Administration, Public Health Service, Dept. of Health & Human Services,. v..

FDA and bioterrorism - your questions answered: complying with Section 306 of the Bioterrorism Act (establishment and maintenance of records) ; a comprehensive reference source based on official transcripts of FDA's seven public meetings on recordkeeping held Jan. 13-Feb. 1, 2005
Washington, DC. Agra Informa. 2005. 96 S..

The FDA and drug registration
Pituk, T. L. ; Harrison, I. H. ; Salek, M. S.
Boca Raton, Fla. ; London. CRC. 2005. 1 v.
ISBN 0-415-25786-7

The FDA and psychiatric drugs: how a drug is approved
Esherick, Joan.
Philadelphia. Mason Crest Publishers,. c2004.. [128] p..

FDA and the Courts
Munsey, Rodney R.
New York. Westminster Publications Inc.. 1969. S. 147 - 197 ; 8-o. Scientia / Lex ; Vol. 5,4.

The FDA and the future of American biomedical and food industries: hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session ... April 5 and 6, 1995.
Washington. U.S. G.P.O.. 1995.. iv, 202 p..

FDA and USDA nutrition labeling guide: decision diagrams, checklists, and regulations
Altman, Tracy A.
Lancaster, Pa. [u.a.]. Technomic Publ.. 1998. Getr. Zählung.
ISBN 1-56676-706-7

FDA-Anforderungen an die cGMP-Compliance: die neue cGMP-Initiative, Inspektionen, Risikoanalyse, Analytik und Qualitätskontrolle, Zulassungsanforderungen ; Anhang: Verzeichnis von Herstellern und Dienstleistern
Aulendorf. ECV, Editio-Cantor-Verl.. 2005. 219 S. : Ill., graph. Darst.. Pharma-Technologie-Journal ; 1087.
ISBN 3-87193-272-8 Pb. (Pr. in Vorb.)

FDA-Anforderungen zur cGMP-Compliance: die neue cGMP-Initiative, Inspektionen, Risikoanalyse, Analytik und Qualitätskontrolle, Zulassungsanforderungen
Aulendorf, Württ. ECV Editio Cantor Verl.. 2004. 216 S.. Pharma-Technologie-Journal ; 1087.2005.
ISBN 3-87193-272-8 Pb. (Pr. in Vorb.)

FDA base: a DMF, VMF & NDA catalogue.
[Dallas, Tex.]. Chemical Information Services, Inc.. CD-ROMs ;.

FDA breast implant consumer handbook, 2004
Rockville, Md.. U.S. Food and Drug Administration,. [2004].

FDA can further improve its adverse drug reaction reporting system: report to the Secretary of Health and Human Services
1901.

FDA clinical experience abstracts.
[Washington] . Food and Drug Administration..

FDA compliance program guidance manual: Section II: Drugs and Biologics, Base Section
Springfield, Va.. U. S. Department of Commerce, National Technical Information Service. 1990. Getrennte Zählung..

FDA consumer: the magazine of the U.S. Food and Drug Administration
Washington, DC. FDA. 1984.

FDA consumer: the official magazine of the Food and Drug Administration
Washington, DC. US Gov. Print. Off.. 1972.

FDA Consumer
Rockville (Md.) . Food and Drug Administration.

FDA consumer nutrition knowledge survey.
Washington, DC, . 1974-..

FDA continues to permit the illegal marketing of carcinogenic additives: twenty-fifth report
Washington. U.S. G.P.O.,. 1987.. v, 37 p. ;.

FDA device inspections manual: revised good manufacturing practices compliance program for FDA investigators
Arlington, Va.. Washinton Business Information. 1991. Getrennte Zählung..
ISBN 0-914176-42-0

FDA directory
Washington, D.C.. FDLI. 2002.

FDA drug approval: a lengthy process that delays the availability of important new drugs : report to the Subcommittee on Science, Research, and Technology, House Committee on Science and Technology
Washington. U.S. General Accounting Office,. 1980.. vi, 83 p. ;.

FDA drug approval: review time has decreased in recent years : report to congressional requesters.
Washington, D.C. (441 G St., NW, Rm. LM, Washington 20548). U.S. General Accounting Office,. [1995]. 44 p..

FDA DRUG APPROVAL : A LENGTHY PROCESS THAT DELAYS THE AVAILABILITY OF IMPORTANT NEW DRUGS ; REPORT TO THE SUBCOMMITTEE ON SCIENCE, RESEARCH, AND TECHNOLOGY, HOUSE COMMITTEE ON SCIENCE AND TECHNOLOGY / BY THE COMPTROLLER GENERAL OF THE UNITED STATES
WASHINGTON, D.C.. U.S. GENERAL ACCOUNTING OFFICE. 1980. VI, 83 S..

FDA drug approvals list
[S.l.], . 1991-.

FDA drug bulletin.
Rockville, Md.. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration,. [1971-1990]. v. ;.

FDA enforcement report
Rockville, Md.. FDA. 1986.

FDA enforcement story
Rockville, Md.. Division of Compliance Policy,. v. ;.

FDA ensures equivalence of generic drugs
Yorke, Jeffrey.
[Rockville, MD] (5600 Fishers Lane, Rockville 20857). [Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Office of Public Affairs,. 1993]. 1 folded sheet (6 p.).

The FDA follies
Burkholz, Herbert
New York. Basic Books. 1994. XII, 228 S..
ISBN 0-465-02369-X

The FDA food additive review process: backlog and failure to observe statutory deadline : fourth report
Washington. U.S. G.P.O.,. 1995.. v, 14 p. ;.

FDA Guidelines for chemistry and technological data requirements for direct food additives and gras food ingredients
Washington, D. C.. 1983. 8 Bl..

FDA-ICMAD simplified guide to cosmetic labeling
Michell, Jerome N. ; Jones, Penni R. ; Sebor, Sheila.
Palatine, IL (1220 W. Northwest Hwy., Palatine 60067-1803). Independent Cosmetic Manufacturers & Distributors,. c1996.. 89 p. ;.

FDA import automation: serious management and systems development problems persist : report to the ranking minority member, Committee on Commerce, House of Representatives
Washington, D.C.. The Office ;. 1995]. 22 p..

FDA Inspection Operations Manual including: Device current good manufacturing practice regulation <21 CFR 820> - Drug current good manufacturing practice regulation <21 CFR 211>
Washington. US. Departm. of Health, Education, and Welfare. 1978. 76 S. [Umschlagt.]..
ISBN 0-914176-12-9

FDA interim index to evaluations published in the federal register for NSA/NRC reviewed prescription drugs
Springfield - Va. . 1978. 3 Microfiches..

FDA investigations operations manual
Rev. ed. Arlington, VA. Washington Business Information. 1994. 541 p..
ISBN 0-914176-60-9 pbk.

FDA laboratories: magnitude of benefits associated with consolidation is questionable : report to congressional requesters
Washington, D.C.. The Office ;. 1996].

FDA medical bulletin
Rockville, MD. Dept. of Health & Human Services, Public Health Service, Food and Drug Administration,. [1991]-1999. 9 v. ;.

FDA, Merck, and Vioxx: putting patient safety first? : hearing before the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, November 18, 2004.
Washington. U.S. G.P.O.. 2005.. iv, 921 p..

FDA milestones in women's health: looking back as we begin 21st century.
[Rockville, Md.?]. U.S. Food and Drug Administration, Office of Women's Health,. [2002?].. 13, [1] p..

FDA Modernization Act: implementation of the law ; hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session on examining the Food and Drug Administration Modernization Act (P.L. 105-115), focusing on provisions on pharmaceuticals and medical devices, October 21, 1999
Washington. U.S. G.P.O. 2000. iv, 189 p.. S. hrg ; 106-156.
ISBN 0-16-060087-1

FDA narcotic treatment programs directory
[Rockville, Md.]: . U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration.

F. D. A.- Nyt. Frivillig dansk Arbejdstjeneste. 2.-4. Aargang. 1945-47. Beg. illegal
Aarhus,, Kbh. 1 bd..

FDA oversight, food inspection: hearings before the Subcommittee on Public Health and Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, 92. Congress, 1. session, on oversight of food inspection activities of the federal government ; August 3,4; September 10, 13, and 14, 1971
Washington. U.S. Gov. Print. Off.. 1972. VI, 474 S..

FDA papers: the official magazine of the Food and Drug Administration,
Washington, DC. US Gov.Print.Off.. 1967.

FDA pesticide analytical manual: (also: PAM)
Springfield - Va. . National technical information Service. 1982. 2 vol.[in 4 parts]..

FDA regulated products & pregnant women: executive summary.
[Washington, D.C.?]. U.S. Food and Drug Administration, Office of Women's Health,. [1994?]. 52 p. ;.

FDA regulation: moving toward a black market in information
Calfee, John E.
p. 34-41 ;.

FDA regulation of blood safety: notification, recall, and enforcement practices : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, June 5, 1997
Washington. U.S. G.P.O.. 1998. iii, 300 p. ;.

FDA regulation of medical devices
Thompson, Bradley Merrill
Buffalo Grove, IL. Interpharm Press. 1995. xviii, 497 p..
ISBN 0-935184-79-1

FDA regulation of medical devices, including the status of breast implants: joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995.
Washington, DC. U.S. G.P.O.. [1996]. vi, 206 p..

FDA regulatory affairs: a guide for prescription drugs, medical devices and biologics
Pisano, Douglas J.
Boca Raton, Fla. [u.a.]. CRC Press. 2004. 360 S..
ISBN 1-587-16007-2 : £32.99

FDA report on the oral contraceptives.
[Washington; . For sale by the Supt. of Docs., U.S. Govt. Print. Off.]. 1966.. iii, 104 p..

FDA review times: statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives.
Hamilton, Mary R.
Washington, D.C. (441 G St., NW, Rm. Lm, Washington 20548). U.S. General Accounting Office,. [1996]. 13, [2] p..

FDA's annual financial report
Rockville, Md.. U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration,. 2002-.

FDA's catalog of information materials for the food and cosmetic industries
Washington, D.C.. The Bureau,. 1982.. 39 p. ;.

FDA's drug approval process: up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005.
Washington. U.S. G.P.O.. 2005.. iii, 93 p..

FDA services guide: (everything you always wanted to know about services and didn't know where to ask).
[Rockville, Md.. U.S. Food and Drug Administration,. 1974]. 1 vol. (various pagings) ;.

FDA's generic drug application policy: hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988
Washington. U.S. G.P.O.. 1989. iii, 19 p..

FDA's generic drug approval process: hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Washington. U.S. G.P.O.. 1989-1991.. 5 v..

FDA's generic drug enforcement and approval process: hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Washington. U.S. G.P.O.. 1992.. iii, 587 p..

FDA should reduce expensive antibiotic testing and charge fees which more closely reflect cost of certification: report to the Secretary of Health and Human Services
[Stand:] October 28, 1981. Washington, D.C.. U.S. General Accounting Office, Document Handling and Information Services Facility. 1981. IV, 30 S..

FDA's mammography inspections: while some problems need attention, facility compliance is growing : report to congressional committees
Washington, D.C.. The Office ;. 1997]. 39 p..

FDA-speak: a glossary and agency guide
Snyder, Dean E.
2nd ed. Boca Raton, FL [u.a.]. CRC Press. 2002. vi, 361 p..
ISBN 1-574-91129-5

FDA-speak: the Interpharm glossary of acronyms and regulatory terms
Snyder, Dean E.
Buffalo Grove, Ill.. Interpharm Press. 1992.
ISBN 0-935184-30-9

The FDA's regulation of silicone breast implants: a staff report
Washington. U.S. G.P.O.. 1993.. viii, 51 p. ;.

FDA's regulation of the marketing of unapproved new drugs: the case of E-Ferol vitamin E aqueous solution ; hearing before a Subcommittee of the Committee on Gvernment Operations, House of Representatives, 98. Congress, 2. session, May 4, 1984
Washington, D.C.. U. S. Government Print. Office. 1984. IV, 501 S..

FDA's regulation of the marketing of unapproved new drugs: the case of E-ferol vitamin E aqueous solu335 report (to accompany H. Res. 416).
[Washington, D.C.. U.S. G.P.O.,. 2003]. [1] leaf ;.

FDA's role in protecting the public health: examining FDA's review of safety and efficacy concerns in anti-depressant use by children : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, September 23, 2004.
Washington. U.S. G.P.O.. 2005..

FDA veterinarian.
Rockville, Md.. CVM,. 1986-.

FDA warning letters & enforcement in FY 2005: special report
Washington, DC. Thompson. 2006. 14 S. : graph. Darst.. [Guide to good clinical practice ; 13,6, Beil.].